Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Invested Capital (2016 - 2025)

Avanos Medical (AVNS) has disclosed Invested Capital for 13 consecutive years, with $868.5 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 8.94% to $868.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $868.5 million through Dec 2025, down 8.94% year-over-year, with the annual reading at $868.5 million for FY2025, 8.94% down from the prior year.
  • Invested Capital hit $868.5 million in Q4 2025 for Avanos Medical, roughly flat from $871.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.9 billion in Q1 2022 to a low of -$681.5 million in Q2 2025.
  • Historically, Invested Capital has averaged $1.0 billion across 5 years, with a median of $1.4 billion in 2021.
  • Biggest five-year swings in Invested Capital: surged 949.97% in 2024 and later tumbled 934.35% in 2025.
  • Year by year, Invested Capital stood at $1.4 billion in 2021, then grew by 8.35% to $1.5 billion in 2022, then fell by 8.03% to $1.4 billion in 2023, then crashed by 31.66% to $953.8 million in 2024, then dropped by 8.94% to $868.5 million in 2025.
  • Business Quant data shows Invested Capital for AVNS at $868.5 million in Q4 2025, $871.4 million in Q3 2025, and -$681.5 million in Q2 2025.